Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin plus chloroquine vs mefloquine for uncomplicated P. falciparum malaria
NCT00082576Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of azithromycin and chloroquine in Plasmodium falciparum malaria (2 arms), sponsored by Pfizer. Primary endpoint: Parasite clearance. Started Jun 2004; status: completed.
02
Drugs
azithromycinchloroquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00082576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082576.